Weight fluctuation was associated with a greater risk for diabetic kidney disease progression among individuals with type 1 diabetes.

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

Chronic kidney disease (CKD) affects approximately 850 million people worldwide and, if left undiagnosed, can progress to ...

Bicara Therapeutics Inc.’s BCAX share price has dipped by 10.28%, which has investors questioning if this is right time to ...

Neurofilament light chain and glial fibrillary acidic protein level increases were associated with cognitive decline in T2D with obesity.

As World Kidney Day on Thursday, 13 March draws near, it’s important to emphasise the vital link between diabetes and kidney ...

Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...